Primary Hyperaldosteronism
Primary hyperaldosteronism is a hormonal disorder where the adrenal glands produce too much aldosterone, leading to high blood pressure and potential electrolyte imbalances.
Primary Aldosteronism: New Imaging Technique Study
We are comparing a new PET/CT imaging method with a standard test to see which better identifies adrenal tumors in patients with primary aldosteronism. This may help improve treatment for hypertension linked to this condition.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you over 18 years old?
- Are you currently pregnant or breastfeeding?
- Do you have any severe health problems that could affect your treatment?
- Are you taking any medications that could interfere with the study, like certain blood pressure medications or diuretics?
- Do you have a kidney function score (eGFR) of less than 40?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
PentixaFor
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Rijnstate Ziekenhuis Stichting
Internal Medicine
Arnhem, Netherlands
Universitair Medisch Centrum Utrecht
Internal Medicine
De Bilt, Netherlands
Radboud universitair medisch centrum / RADBOUDUMC
Urology
Nijmegen, Netherlands
Sponsor: Stichting Radboud universitair medisch centrum
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.